The pharma industry has an annual meeting at CPhI South East Asia, the best chance to do business in a booming and expanding market as well as keeping up to date about the latest trends, news and topics. We have been talking with the organizers to ask them about the novelties of the Show, and about some useful tips for companies exhibiting in Jakarta for the first time... If this is your case, don't miss any detail.
CPhI celebrates several editions all around the world focusing on the pharma industry. What represents CPhI South East Asia to the annual calendar of the industry in the region?
CPhI South East Asia was launched in 2012 as an addition to the worldwide portfolio pharmaceutical ingredients event. This year it is being held in Jakarta, Indonesia, the fourth-largest populated country in the world, with a large and gradually ageing population.
A greater need for all categories of medicine, particularly generic drugs, has recently propagated in Indonesia with the introduction of a new universal healthcare system from the government. But the flourishing market is not restricted to Indonesia; the entirety of the South East Asian market is expected to continue to mature and grow in the next few years, especially Singapore, Thailand, and Vietnam.
There are new opportunities for manufacturers/CMOS/pharma companies to branch into the South East Asian market as it continues to develop and mature. CPhI South East Asia will host a wide range of networking opportunities to expand business in the market including dedicated forums, innovation tours, seminars, and more. Given that CPhI South East Asia will be held within the largest economy in South East Asia, it is vital that any company wanting to explore and strengthen their position in this market attend CPhI South East Asia.
What are the highlights (novelties) for the next edition, to be held on April?
One highlight of this year’s event is the Innovation Gallery, showcasing the most innovative and revolutionary products within the pharma market. The gallery is situated in the middle of the event for easy access and visibility.
Additionally, the Business Matchmaking Programme returns once again. This is a complimentary service for all attendees to pre-arrange meetings with buyers and suppliers. It helps visitors and exhibitors find the companies that best match their business needs.
Furthermore, there is the P-MEC Route, a dedicated daily tour guide for attendees to have a one-to-one presentation of exhibitors’ latest developments in pharmaceutical machinery and technology.
Can you give some tips to those companies exhibiting for the first time in Jakarta? (Some rules of the venue, customs of the country, protocol...)
Attendees tend to flock to busier and lively stands. For this reason, it is of the utmost importance for exhibitors to design their displays in an appealing and interactive way for attendees to participate with, perhaps by including on-stand demonstrations, videos, easily accessible literature, and even onsite drinks, canapés and talks. Should there be downtime, exhibitors should actively seek other attendees to visit their display.
Some more practical tips involve attire: remain professional, so no shorts, no slippers/flip-flops and informal clothes but comfortable shoes are highly recommended.
Who can - or who must - attend the Show?
The event is open to anyone involved in pharma ingredients, pharmaceutical machinery and technology, pharma packaging, contract manufacturing and services, and healthy ingredients.
Give us at least three reasons to don't miss CPhI South East Asia – focus on why they need to go/ what it is an unmissable opportunity as businessmen/pharma people
- CPhI South East Asia 2016 will co-locate with P-MEC, InnoPack, ICSE and Hi South East Asia. This is the first time that both ICSE and Hi South East Asia will co-locate with these events, which creates an opportunity that any business leader in regional pharma will not want to miss. These events provide an opportunity collectively greater than the sum of their parts.
- The recent implementation of the ASEAN Economic Community will allow for an increased opportunity for trade and commerce within South East Asia, and as healthcare has been identified as a key sector for this to effect, there is a very high potential for international pharma companies to enter the South East Asian pharmaceutical market.
- Indonesia imports over 95% of the pharmaceutical ingredients it uses and this number continue to increase. The first half of 2015 saw the value of imports rise 17%, to USD 296 million. International participation in this market is vital to Indonesia’s growing economy, and CPhI South East Asia is the best venue to discuss new market trends and showcase new innovations.
Finally, can you give us some participation results from the last edition?
CPhI noted a significant influx of foreign companies seeking new business and partnerships within the region; 231 companies, from 64 different countries exhibited at the three-day event as well as 3056 visitors.